Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7714056

Concept 2018-04-01 to
2018-12-31
2017-04-01 to
2017-12-31
Consolidated statement of income
Statement of income
Net sales
154,621,000 JPY
246,634,000 JPY
Cost of sales
70,147,000 JPY
240,058,000 JPY
Operating expenses
Selling, general and administrative expenses
1,364,532,000 JPY
1,176,105,000 JPY
Operating expenses
Ordinary profit (loss)
-1,272,609,000 JPY
-1,172,418,000 JPY
Operating profit (loss)
-1,280,059,000 JPY
-1,169,529,000 JPY
Gross profit (loss)
84,473,000 JPY
6,576,000 JPY
Net sales
Cost of sales
Selling, general and administrative expenses
Non-operating income
Interest income
31,000 JPY
23,000 JPY
Other
705,000 JPY
17,000 JPY
Non-operating income
11,349,000 JPY
341,000 JPY
Non-operating expenses
Other
JPY
409,000 JPY
Non-operating expenses
3,899,000 JPY
3,230,000 JPY
Share issuance costs
JPY
292,000 JPY
Extraordinary losses
194,215,000 JPY
JPY
Impairment losses
193,800,000 JPY
JPY
Other
415,000 JPY
JPY
Profit (loss) before income taxes
-1,466,825,000 JPY
-1,172,418,000 JPY
Gross profit
Income taxes - current
2,887,000 JPY
3,572,000 JPY
Income taxes - deferred
234,000 JPY
696,000 JPY
Extraordinary losses
Income taxes
3,122,000 JPY
4,268,000 JPY
Profit (loss)
-1,469,947,000 JPY
-1,176,687,000 JPY
Profit (loss) attributable to non-controlling interests
JPY
-1,274,000 JPY
Profit (loss) attributable to owners of parent
-1,469,947,000 JPY
-1,175,412,000 JPY
Profit attributable to
Comprehensive income
-1,469,947,000 JPY
-1,176,687,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-1,469,947,000 JPY
-1,175,412,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
-1,274,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.